Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 105 articles:
HTML format
Text format



Single Articles


    May 2018
  1. WANG Y, Guan G, Cheng W, Jiang Y, et al
    ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.
    BMC Cancer. 2018;18:599.
    PubMed     Text format     Abstract available


  2. MARTINI M, de Pascalis I, D'Alessandris QG, Fiorentino V, et al
    VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.
    BMC Cancer. 2018;18:553.
    PubMed     Text format     Abstract available


  3. LEE C, Lee J, Choi SA, Kim SK, et al
    M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas.
    BMC Cancer. 2018;18:535.
    PubMed     Text format     Abstract available


  4. SCHULZE M, Hutterer M, Sabo A, Hoja S, et al
    Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions.
    BMC Cancer. 2018;18:524.
    PubMed     Text format     Abstract available


  5. HEGGE B, Sjottem E, Mikkola I
    Generation of a PAX6 knockout glioblastoma cell line with changes in cell cycle distribution and sensitivity to oxidative stress.
    BMC Cancer. 2018;18:496.
    PubMed     Text format     Abstract available


    April 2018
  6. VOSOUGHI E, Lee JM, Miller JR, Nosrati M, et al
    Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies.
    BMC Cancer. 2018;18:490.
    PubMed     Text format     Abstract available


  7. JIN J, Gao Y, Zhang J, Wang L, et al
    Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
    BMC Cancer. 2018;18:446.
    PubMed     Text format     Abstract available


  8. CHIO CC, Chen KY, Chang CK, Chuang JY, et al
    Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
    BMC Cancer. 2018;18:379.
    PubMed     Text format     Abstract available


  9. BOTTCHER MA, Held-Feindt J, Synowitz M, Lucius R, et al
    Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation.
    BMC Cancer. 2018;18:376.
    PubMed     Text format     Abstract available


  10. FATAI AA, Gamieldien J
    A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
    BMC Cancer. 2018;18:377.
    PubMed     Text format     Abstract available


    March 2018
  11. AABERG-JESSEN C, Sorensen MD, Matos ALSA, Moreira JM, et al
    Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.
    BMC Cancer. 2018;18:270.
    PubMed     Text format     Abstract available


  12. RANJAN S, Quezado M, Garren N, Boris L, et al
    Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.
    BMC Cancer. 2018;18:239.
    PubMed     Text format     Abstract available


    February 2018
  13. HAN Y, Yan LF, Wang XB, Sun YZ, et al
    Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
    BMC Cancer. 2018;18:215.
    PubMed     Text format     Abstract available


  14. SCHIMMEL WCM, Verhaak E, Hanssens PEJ, Gehring K, et al
    A randomised trial to compare cognitive outcome after gamma knife radiosurgery versus whole brain radiation therapy in patients with multiple brain metastases: research protocol CAR-study B.
    BMC Cancer. 2018;18:218.
    PubMed     Text format     Abstract available


  15. TOTON E, Romaniuk A, Konieczna N, Hofmann J, et al
    Impact of PKCepsilon downregulation on autophagy in glioblastoma cells.
    BMC Cancer. 2018;18:185.
    PubMed     Text format     Abstract available


  16. AHN MJ, Lee K, Lee KH, Kim JW, et al
    Combination of anti-PD-1 therapy and stereotactic radiosurgery for a gastric cancer patient with brain metastasis: a case report.
    BMC Cancer. 2018;18:173.
    PubMed     Text format     Abstract available


  17. VASAIKAR S, Tsipras G, Landazuri N, Costa H, et al
    Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
    BMC Cancer. 2018;18:154.
    PubMed     Text format     Abstract available


  18. LIU F, Huang J, Zhang L, Fan F, et al
    Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis.
    BMC Cancer. 2018;18:124.
    PubMed     Text format     Abstract available


    January 2018
  19. EISEMANN T, Costa B, Strelau J, Mittelbronn M, et al
    An advanced glioma cell invasion assay based on organotypic brain slice cultures.
    BMC Cancer. 2018;18:103.
    PubMed     Text format     Abstract available


  20. CHOU SY, Yen SL, Huang CC, Huang EY, et al
    Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy.
    BMC Cancer. 2018;18:105.
    PubMed     Text format     Abstract available


  21. RICCIARDI GRR, Russo A, Franchina T, Schifano S, et al
    Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.
    BMC Cancer. 2018;18:97.
    PubMed     Text format     Abstract available


  22. GOLDSMITH CS, Kim SM, Karunarathna N, Neuendorff N, et al
    Inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness.
    BMC Cancer. 2018;18:43.
    PubMed     Text format     Abstract available


  23. XIA L, Fang C, Chen G, Sun C, et al
    Relationship between the extent of resection and the survival of patients with low-grade gliomas: a systematic review and meta-analysis.
    BMC Cancer. 2018;18:48.
    PubMed     Text format     Abstract available


  24. STRAUBE C, Scherb H, Gempt J, Kirschke J, et al
    Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
    BMC Cancer. 2018;18:15.
    PubMed     Text format     Abstract available


    December 2017
  25. CHANG CH, Liu WT, Hung HC, Gean CY, et al
    Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
    BMC Cancer. 2017;17:905.
    PubMed     Text format     Abstract available


  26. CONDE M, Michen S, Wiedemuth R, Klink B, et al
    Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.
    BMC Cancer. 2017;17:889.
    PubMed     Text format     Abstract available


    November 2017
  27. YOMO S, Oguchi K
    Prospective study of 11C-methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment.
    BMC Cancer. 2017;17:713.
    PubMed     Text format     Abstract available


    October 2017
  28. TRAN LT, Lai HTM, Koriyama C, Uwatoko F, et al
    The association between high birth weight and the risks of childhood CNS tumors and leukemia: an analysis of a US case-control study in an epidemiological database.
    BMC Cancer. 2017;17:687.
    PubMed     Text format     Abstract available


    August 2017
  29. NOH MG, Oh SJ, Ahn EJ, Kim YJ, et al
    Prognostic significance of E-cadherin and N-cadherin expression in Gliomas.
    BMC Cancer. 2017;17:583.
    PubMed     Text format     Abstract available


    July 2017
  30. ZINDLER JD, Bruynzeel AME, Eekers DBP, Hurkmans CW, et al
    Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    BMC Cancer. 2017;17:500.
    PubMed     Text format     Abstract available


  31. MIELE E, Po A, Begalli F, Antonucci L, et al
    beta-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.
    BMC Cancer. 2017;17:488.
    PubMed     Text format     Abstract available


    June 2017
  32. WIBROE M, Cappelen J, Castor C, Clausen N, et al
    Cerebellar mutism syndrome in children with brain tumours of the posterior fossa.
    BMC Cancer. 2017;17:439.
    PubMed     Text format     Abstract available


  33. HAYASHI N, Takahashi H, Hasegawa Y, Higuchi F, et al
    A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.
    BMC Cancer. 2017;17:397.
    PubMed     Text format     Abstract available


    May 2017
  34. TEYSSONNEAU D, Daste A, Dousset V, Hoepffner JL, et al
    Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
    BMC Cancer. 2017;17:323.
    PubMed     Text format     Abstract available


    April 2017
  35. URUP T, Staunstrup LM, Michaelsen SR, Vitting-Seerup K, et al
    Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients.
    BMC Cancer. 2017;17:278.
    PubMed     Text format     Abstract available


  36. TRUBICKA J, Zemojtel T, Hecht J, Falana K, et al
    The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies.
    BMC Cancer. 2017;17:239.
    PubMed     Text format     Abstract available


  37. LI MX, He H, Ruan ZH, Zhu YX, et al
    Central nervous system progression in advanced non-small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study.
    BMC Cancer. 2017;17:245.
    PubMed     Text format     Abstract available


    March 2017
  38. DALAN AB, Gulluoglu S, Tuysuz EC, Kuskucu A, et al
    Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.
    BMC Cancer. 2017;17:207.
    PubMed     Text format     Abstract available


  39. NARAYAN RS, Fedrigo CA, Brands E, Dik R, et al
    The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures.
    BMC Cancer. 2017;17:204.
    PubMed     Text format     Abstract available


  40. JENSEN SS, Petterson SA, Halle B, Aaberg-Jessen C, et al
    Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
    BMC Cancer. 2017;17:178.
    PubMed     Text format     Abstract available


    February 2017
  41. PANOSYAN EH, Lin HJ, Koster J, Lasky JL 3rd, et al
    In search of druggable targets for GBM amino acid metabolism.
    BMC Cancer. 2017;17:162.
    PubMed     Text format     Abstract available


  42. DEWAN R, Pemov A, Dutra AS, Pak ED, et al
    First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    BMC Cancer. 2017;17:127.
    PubMed     Text format     Abstract available


  43. LI Y, Li J, Woo YM, Shen Z, et al
    Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model.
    BMC Cancer. 2017;17:126.
    PubMed     Text format     Abstract available


  44. SHANNON S, Jia D, Entersz I, Beelen P, et al
    Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901.
    BMC Cancer. 2017;17:121.
    PubMed     Text format     Abstract available


  45. GERSEY ZC, Rodriguez GA, Barbarite E, Sanchez A, et al
    Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
    BMC Cancer. 2017;17:99.
    PubMed     Text format     Abstract available


    January 2017
  46. DENG X, Zheng Z, Lin B, Su H, et al
    The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    BMC Cancer. 2017;17:42.
    PubMed     Text format     Abstract available


  47. RADES D, Janssen S, Dziggel L, Blanck O, et al
    A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases.
    BMC Cancer. 2017;17:30.
    PubMed     Text format     Abstract available


  48. FROMBERG A, Rabe M, Oppermann H, Gaunitz F, et al
    Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
    BMC Cancer. 2017;17:3.
    PubMed     Text format     Abstract available


    December 2016
  49. YOMO S, Hayashi M
    Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
    BMC Cancer. 2016;16:948.
    PubMed     Text format     Abstract available


    November 2016
  50. WONG ET, Timmons J, Callahan A, O'Loughlin L, et al
    Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
    BMC Cancer. 2016;16:914.
    PubMed     Text format     Abstract available


  51. MUROTA Y, Tabu K, Taga T
    Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes.
    BMC Cancer. 2016;16:847.
    PubMed     Text format     Abstract available


    October 2016
  52. OEHLKE O, Mix M, Graf E, Schimek-Jasch T, et al
    Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    BMC Cancer. 2016;16:769.
    PubMed     Text format     Abstract available


    April 2016
  53. GRAMATZKI D, Roth P, Felsberg J, Hofer S, et al
    Chemotherapy for intracranial ependymoma in adults.
    BMC Cancer. 2016;16:287.
    PubMed     Text format     Abstract available


    January 2016
  54. AKIMOTO J, Fukuhara H, Suda T, Nagai K, et al
    Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain.
    BMC Cancer. 2016;16:36.
    PubMed     Text format     Abstract available


  55. ZHANG C, Zhu Q, He H, Jiang L, et al
    Erratum to: RIZ1: a potential tumor suppressor in glioma.
    BMC Cancer. 2016;16:26.
    PubMed     Text format    


  56. LEGENDRE C, Avril S, Guillet C, Garcion E, et al
    Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells.
    BMC Cancer. 2016;16:51.
    PubMed     Text format     Abstract available


  57. DIETL S, Schwinn S, Dietl S, Riedel S, et al
    MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties.
    BMC Cancer. 2016;16:115.
    PubMed     Text format     Abstract available


  58. SIVAK S, Kantorova E, Kurca E, Marcinek J, et al
    Primary diffuse leptomeningeal gliomatosis as a rare cause of pain in cervical spine.
    BMC Cancer. 2016;16:182.
    PubMed     Text format     Abstract available


  59. AYALA-ORTEGA E, Arzate-Mejia R, Perez-Molina R, Gonzalez-Buendia E, et al
    Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.
    BMC Cancer. 2016;16:226.
    PubMed     Text format     Abstract available


  60. CHRISTENSEN TD, Spindler KL, Palshof JA, Nielsen DL, et al
    Systematic review: brain metastases from colorectal cancer-Incidence and patient characteristics.
    BMC Cancer. 2016;16:260.
    PubMed     Text format     Abstract available


  61. LUSSIER DM, Woolf EC, Johnson JL, Brooks KS, et al
    Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet.
    BMC Cancer. 2016;16:310.
    PubMed     Text format     Abstract available


  62. NAVARRIA P, Pessina F, Cozzi L, Ascolese AM, et al
    Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvan
    BMC Cancer. 2016;16:362.
    PubMed     Text format     Abstract available


  63. CHEN BB, Lu YS, Lin CH, Chen WW, et al
    A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer.
    BMC Cancer. 2016;16:466.
    PubMed     Text format     Abstract available


  64. GROSSMANN P, Gutman DA, Dunn WD Jr, Holder CA, et al
    Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
    BMC Cancer. 2016;16:611.
    PubMed     Text format     Abstract available


  65. BALBOUS A, Cortes U, Guilloteau K, Rivet P, et al
    A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells.
    BMC Cancer. 2016;16:604.
    PubMed     Text format     Abstract available


  66. NETLAND IA, Forde HE, Sleire L, Leiss L, et al
    Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models.
    BMC Cancer. 2016;16:657.
    PubMed     Text format     Abstract available


  67. AMANI V, Prince EW, Alimova I, Balakrishnan I, et al
    Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
    BMC Cancer. 2016;16:647.
    PubMed     Text format     Abstract available


  68. CHOI SA, Kwak PA, Kim SK, Park SH, et al
    In vivo bioluminescence imaging for leptomeningeal dissemination of medulloblastoma in mouse models.
    BMC Cancer. 2016;16:723.
    PubMed     Text format     Abstract available


  69. SCHORB E, Finke J, Ferreri AJ, Ihorst G, et al
    High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma-a randomized phase III trial (MATRix).
    BMC Cancer. 2016;16:282.
    PubMed     Text format     Abstract available


  70. NIIBE Y, Nishimura T, Inoue T, Karasawa K, et al
    Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    BMC Cancer. 2016;16:659.
    PubMed     Text format     Abstract available


  71. FLECKENSTEIN J, Petroff A, Schafers HJ, Wehler T, et al
    Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    BMC Cancer. 2016;16:348.
    PubMed     Text format     Abstract available


  72. KIM S, Nam SJ, Kwon D, Kim H, et al
    MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
    BMC Cancer. 2016;16:363.
    PubMed     Text format     Abstract available


  73. ANGELINO G, De Pasquale MD, De Sio L, Serra A, et al
    NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications.
    BMC Cancer. 2016;16:512.
    PubMed     Text format     Abstract available


    May 2015
  74. KIM DW, Barcena E, Mehta UN, Rohlfs ML, et al
    Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report.
    BMC Cancer. 2015;15:400.
    PubMed     Text format     Abstract available


    April 2015
  75. GAO Y, Li G, Sun L, He Y, et al
    ACTN4 and the pathways associated with cell motility and adhesion contribute to the process of lung cancer metastasis to the brain.
    BMC Cancer. 2015;15:277.
    PubMed     Text format     Abstract available


    January 2015
  76. TIAN Y, Xie Q, He J, Luo X, et al
    Radioactive (125)I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway.
    BMC Cancer. 2015;15:1.
    PubMed     Text format     Abstract available


  77. MICALE L, Fusco C, Fontana A, Barbano R, et al
    TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival.
    BMC Cancer. 2015;15:470.
    PubMed     Text format     Abstract available


  78. GIMENEZ M, Marie SK, Oba-Shinjo S, Uno M, et al
    Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.
    BMC Cancer. 2015;15:481.
    PubMed     Text format     Abstract available


  79. SCORSETTI M, Navarria P, Pessina F, Ascolese AM, et al
    Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.
    BMC Cancer. 2015;15:486.
    PubMed     Text format     Abstract available


  80. TOWNER RA, Ihnat M, Saunders D, Bastian A, et al
    A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
    BMC Cancer. 2015;15:522.
    PubMed     Text format     Abstract available


  81. HAUSWALD H, Stenke A, Debus J, Combs SE, et al
    Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma.
    BMC Cancer. 2015;15:537.
    PubMed     Text format     Abstract available


  82. ADEBERG S, Bostel T, Harrabi S, Bernhardt D, et al
    Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma.
    BMC Cancer. 2015;15:558.
    PubMed     Text format     Abstract available


  83. OZAWA Y, Omae M, Fujii M, Matsui T, et al
    Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
    BMC Cancer. 2015;15:589.
    PubMed     Text format     Abstract available


  84. HAN S, Liu Y, Li Q, Li Z, et al
    Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma.
    BMC Cancer. 2015;15:617.
    PubMed     Text format     Abstract available


  85. ADKINS CE, Nounou MI, Hye T, Mohammad AS, et al
    NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.
    BMC Cancer. 2015;15:685.
    PubMed     Text format     Abstract available


  86. FABBRI E, Brognara E, Montagner G, Ghimenton C, et al
    Regulation of IL-8 gene expression in gliomas by microRNA miR-93.
    BMC Cancer. 2015;15:661.
    PubMed     Text format     Abstract available


  87. LAMBERTZ N, El Hindy N, Kreitschmann-Andermahr I, Stein KP, et al
    Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.
    BMC Cancer. 2015;15:759.
    PubMed     Text format     Abstract available


  88. MARTINEZ R, Stuhmer W, Martin S, Schell J, et al
    Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.
    BMC Cancer. 2015;15:839.
    PubMed     Text format     Abstract available


  89. GU XD, Cai YT, Zhou YM, Li ZY, et al
    Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients.
    BMC Cancer. 2015;15:902.
    PubMed     Text format     Abstract available


  90. WEISS S, Darvishian F, Tadepalli J, Shapiro R, et al
    Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis.
    BMC Cancer. 2015;15:926.
    PubMed     Text format     Abstract available


  91. CHAN V, Pole JD, Mann RE, Colantonio A, et al
    A population based perspective on children and youth with brain tumours.
    BMC Cancer. 2015;15:1007.
    PubMed     Text format     Abstract available


  92. ZHANG C, Zhu Q, He H, Jiang L, et al
    RIZ1: a potential tumor suppressor in glioma.
    BMC Cancer. 2015;15:990.
    PubMed     Text format     Abstract available


  93. LEE SJ, Kang WY, Yoon Y, Jin JY, et al
    Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.
    BMC Cancer. 2015;15:1011.
    PubMed     Text format     Abstract available


  94. CHENG CL, Li CC, Hou HA, Fang WQ, et al
    Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults.
    BMC Cancer. 2015;15:344.
    PubMed     Text format     Abstract available


  95. WU PF, Lin CH, Kuo CH, Chen WW, et al
    A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis.
    BMC Cancer. 2015;15:299.
    PubMed     Text format     Abstract available


  96. GAO H, Wang F, Lan X, Li C, et al
    Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
    BMC Cancer. 2015;15:272.
    PubMed     Text format     Abstract available


  97. RESENDE FF, Bai X, Del Bel EA, Kirchhoff F, et al
    Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction.
    BMC Cancer. 2016;16:72.
    PubMed     Text format     Abstract available


  98. JUNGK C, Chatziaslanidou D, Ahmadi R, Capper D, et al
    Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naive patients.
    BMC Cancer. 2016;16:81.
    PubMed     Text format     Abstract available


  99. YANG L, Fujimoto J
    Childhood cancer mortality in Japan, 1980-2013.
    BMC Cancer. 2015;15:446.
    PubMed     Text format     Abstract available


  100. TANAKA T, Hiramatsu K, Nosaka T, Saito Y, et al
    Pituitary metastasis of hepatocellular carcinoma presenting with panhypopituitarism: a case report.
    BMC Cancer. 2015;15:863.
    PubMed     Text format     Abstract available


    October 2014
  101. ZHANG W, Jiang W, Luan L, Wang L, et al
    Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysis.
    BMC Cancer. 2014;14:793.
    PubMed     Text format     Abstract available


    September 2014
  102. VAN LAAR M, Stark DP, McKinney P, Parslow RC, et al
    Population mixing for leukaemia, lymphoma and CNS tumours in teenagers and young adults in England, 1996-2005.
    BMC Cancer. 2014;14:698.
    PubMed     Text format     Abstract available


    August 2014
  103. SHAPOVALOV Y, Zettel M, Spielman SC, Amico-Ruvio SA, et al
    Fluoxetine modulates breast cancer metastasis to the brain in a murine model.
    BMC Cancer. 2014;14:598.
    PubMed     Text format     Abstract available


    January 2014
  104. RADES D, Huttenlocher S, Hornung D, Blanck O, et al
    Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer.
    BMC Cancer. 2014;14:931.
    PubMed     Text format     Abstract available


  105. LIU BL, Liu SJ, Baskys A, Cheng H, et al
    Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.
    BMC Cancer. 2014;14:829.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: